Learning Objectives:

  1. Identify patients with interstitial lung disease, severe COPD, asthma, thromboembolic disease or recurrent infections who are candidates for cutting edge therapies.
  2. Apply therapies derived from evidence based research articles.
  3. Use the journal club forum to debate and critique articles to keep Inova Pulmonary on the cutting edge of pulmonary care.
Session date: 
08/27/2025 - 12:30pm to 1:00pm EDT
Location: 
Virtual
United States
See map: Google Maps
Add to calendar: 
  • 0.50 AMA PRA Category 1 Credit™
Please login or register to take this course.
Faculty List: 
Program Director(s)

Eric Libre, Eric Libre, MD, FACP, FCCP

has a financial relationship (Consulting Fee) with GlaxoSmithKline;.
has a financial relationship (Consulting Fee) with AstraZeneca;.
Speaker(s)

Eric Libre, Eric Libre, MD, FACP, FCCP

has a financial relationship (Consulting Fee) with GlaxoSmithKline;.
has a financial relationship (Consulting Fee) with AstraZeneca;.